Author: Patrice Milos

Measles in America: Why vaccination matters

Maimuna (Maia) Majumder is an engineering systems PhD student at MIT and computational epidemiology research fellow at HealthMap.

The 2015 Disneyland measles outbreak in the United States, which started in late December and spread to more than 100 people in just 6 weeks, has recently become the subject of substantial media scrutiny.

Measles is extremely infectious, exhibiting a basic reproductive number between 12 and 18—one of the highest recorded in history. This means that for every 1 case who gets sick in a totally susceptible population, 12 to 18 other folks get sick, too. Thankfully, when uptake of the measles vaccine is high enough in a given community, it’s almost impossible for the disease to spread—thus halting a potential outbreak in its tracks.

But what happens when vaccine rates aren’t high enough?

Read Full Story | Leave a Comment

The Precision Medicine Initiative: A child-centered perspective

child aiming bow & arrow Shutterstock croppedPatrice Milos, PhD, is president and CEO of Claritas Genomics, a CLIA-certified genetic diagnostic testing company spun off from Boston Children’s Hospital in 2013.

A child is sick, showing symptoms her parents cannot identify. Something is seriously wrong, but what? The family turns to Boston Children’s Hospital for answers. Yet, even with today’s medical advances, a precise diagnosis often remains elusive.

The Human Genome Project has sparked innovation over the last 14 years, and as President Obama’s Precision Medicine Initiative asserts, today genome science offers patients new hope for answers.

Initially, cancer will be the major medical focus of this initiative, as cancer is a genetic disease—a genomic alternation of the patient’s normal tissue DNA.

Read Full Story | Leave a Comment